CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 1190-1463 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T10","span":{"begin":0,"end":273},"obj":"Sentence"}],"text":"The relapsing-remitting phase is characterized by clinical symptoms such as loss of visual acuity, weakness, ataxia, fatigue, and clumsiness that develop over a period of several days, stabilize, and then resolve over the course of several weeks (Noseworthy et al., 2000) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T10","span":{"begin":0,"end":273},"obj":"Sentence"},{"id":"TextSentencer_T10","span":{"begin":0,"end":273},"obj":"Sentence"},{"id":"T18666","span":{"begin":0,"end":273},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The relapsing-remitting phase is characterized by clinical symptoms such as loss of visual acuity, weakness, ataxia, fatigue, and clumsiness that develop over a period of several days, stabilize, and then resolve over the course of several weeks (Noseworthy et al., 2000) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6","span":{"begin":109,"end":115},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0000437"}],"text":"The relapsing-remitting phase is characterized by clinical symptoms such as loss of visual acuity, weakness, ataxia, fatigue, and clumsiness that develop over a period of several days, stabilize, and then resolve over the course of several weeks (Noseworthy et al., 2000) ."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T5","span":{"begin":76,"end":97},"obj":"Phenotype"},{"id":"T6","span":{"begin":109,"end":115},"obj":"Phenotype"},{"id":"T7","span":{"begin":117,"end":124},"obj":"Phenotype"},{"id":"T8","span":{"begin":130,"end":140},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0000529"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0001251"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0012378"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002312"}],"text":"The relapsing-remitting phase is characterized by clinical symptoms such as loss of visual acuity, weakness, ataxia, fatigue, and clumsiness that develop over a period of several days, stabilize, and then resolve over the course of several weeks (Noseworthy et al., 2000) ."}